Your browser doesn't support javascript.
loading
Prevalence of congenital heart defects in Europe, 2008-2015: A registry-based study.
Mamasoula, Chrysovalanto; Addor, Marie-Claude; Carbonell, Clara Cavero; Dias, Carlos M; Echevarría-González-de-Garibay, Luis-Javier; Gatt, Miriam; Khoshnood, Babak; Klungsoyr, Kari; Randall, Kay; Stoianova, Sylvia; Haeusler, Martin; Nelen, Vera; Neville, Amanda J; Perthus, Isabelle; Pierini, Anna; Bertaut-Nativel, Bénédicte; Rissmann, Anke; Rouget, Florence; Schaub, Bruno; Tucker, David; Wellesley, Diana; Zymak-Zakutnia, Natalya; Barisic, Ingeborg; de Walle, Hermien E K; Lanzoni, Monica; Mullaney, Carmel; Pennington, Lindsay; Rankin, Judith.
Afiliación
  • Mamasoula C; Population Health Sciences Institute, Newcastle University, Newcastle, UK.
  • Addor MC; Department of Woman-Mother-Child, University Medical Center CHUV, Lausanne, Switzerland.
  • Carbonell CC; Rare Diseases Research Unit, Foundation for the Promotion of Health and Biomedical Research in the Valencian Region, Valencia, Spain.
  • Dias CM; Epidemiology Department, National Institute of Health Doutor Ricardo Jorge, Lisbon, Portugal.
  • Echevarría-González-de-Garibay LJ; Directorate for Healthcare Planning, Organisation and Evaluation; Registries and Health Information Unit, Ministry of Health of the Basque Government, Vitoria-Gasteiz, Spain.
  • Gatt M; Malta Congenital Anomalies Register, Directorate for Health Information and Research, Pietà, Malta.
  • Khoshnood B; INSERM U1153, CRESS, Obstetrical Perinatal and Pediatric Epidemiology Research Team (EPOPé), Université de Paris, Paris, France.
  • Klungsoyr K; Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway.
  • Randall K; Division for Mental and Physical Health, Norwegian Institute of Public Health, Bergen, Norway.
  • Stoianova S; National Perinatal Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
  • Haeusler M; South West Congenital Anomaly Register (SWCAR), Bristol Medical School, University of Bristol, Bristol, UK.
  • Nelen V; Styrian Malformation Registry, Medical University of Graz, Graz, Austria.
  • Neville AJ; Provinciaal Instituut voor Hygiene (PIH), Antwerp, Belgium.
  • Perthus I; Registro IMER - IMER Registry (Emilia Romagna Registry of Birth Defects), Center for Clinical and Epidemiological Research, University of Ferrara, Azienda Ospedaliero-Universitaria di Ferrara, Ferrara, Italy.
  • Pierini A; Auvergne Registry of Congenital Anomalies (CEMC-Auvergne), Department of Clinical Genetics, Centre de Référence des Maladies Rares, University Hospital of Clermont-Ferrand, Clermont-Ferrand, France.
  • Bertaut-Nativel B; Tuscany Registry of Congenital Defects (RTDC), Institute of Clinical Physiology - National Research Council/Fondazione Toscana Gabriele Monasterio, Pisa, Italy.
  • Rissmann A; Register of Congenital Malformations of Reunion Island, CHU Réunion, St Pierre, France.
  • Rouget F; Malformation Monitoring Centre Saxony-Anhalt, Medical Faculty, Otto-von-Guericke University, Magdeburg, Germany.
  • Schaub B; Brittany Registry of Congenital Anomalies, CHU Rennes, University Rennes, Inserm, EHESP, Irset (Institut de Recherche en Santé, Environnement Ettravail), Rennes, France.
  • Tucker D; French West Indies Registry, Registre des Malformations des Antilles (REMALAN), Maison de la Femme de la Mère et de l'Enfant, University Hospital of Martinique, Fort-de-France, France.
  • Wellesley D; CARIS, Public Health Wales, Singleton Hospital, Swansea, UK.
  • Zymak-Zakutnia N; Wessex Clinical Genetics Department, Princess Anne Hospital, Southampton, UK.
  • Barisic I; OMNI-Net Ukraine Birth Defects Program, Khmelnytsky City Children's Hospital, Khmelnytsky, Ukraine.
  • de Walle HEK; Centre of Excellence for Reproductive and Regenerative Medicine, Children's Hospital Zagreb, Medical School University of Zagreb, Zagreb, Croatia.
  • Lanzoni M; Department of Genetics, EUROCAT Northern Netherlands, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
  • Mullaney C; European Commission, Joint Research Centre (JRC), Ispra, Italy.
  • Pennington L; Department of Public Health, Health Service Executive (HSE) South East Area, Dublin, Ireland.
  • Rankin J; Population Health Sciences Institute, Newcastle University, Newcastle, UK.
Birth Defects Res ; 114(20): 1404-1416, 2022 12 01.
Article en En | MEDLINE | ID: mdl-36345679
BACKGROUND: The total prevalence of congenital heart defects (CHDs) varies by populations and over time. Studies that examine trends in the prevalence of CHD in different regions may shed light on our understanding of the occurrence of CHD and the impact of different risk factors. OBJECTIVES: To examine trends in total and live birth prevalence of nonsyndromic CHD in Europe between the years 2008 and 2015 and to investigate if the decreasing trend reported by previous studies is continuing. METHODS: Cases of CHD delivered between January 1, 2008 and December 31, 2015 notified to 25 population-based EUROCAT (European Surveillance of Congenital Anomalies) registries in 14 countries, formed the population-based case-series. Prevalence (total/live) rates and 95% confidence intervals were calculated as the number of cases per 10,000 births (live and stillbirths). Time trends in prevalence of all nonsyndromic CHDs and for three CHD severity groups (very severe, severe, and less severe) were plotted using a Poisson regression multilevel approach. RESULTS: The total prevalence of nonsyndromic CHD was 57.1 per 10,000 births (live births and stillbirths) for the 8-year period and remained stable across the three CHD severity groups while the live birth prevalence was 60.2 per 10,000 births. There was considerable variation in the reported total CHD prevalence and the direction of trends by registry. A decreasing prevalence of CHD was observed for the Norway and England/Wales registries, whereas the CHD prevalence increased for registries in Italy and Croatia. CONCLUSIONS: The total prevalence of CHD in Europe between the years 2008 and 2015 remained stable for all CHD and across the three CHD severity groups. The decreasing trend reported by previous studies has not continued. However, we found significant differences in the total and live birth prevalence by registry.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Mortinato / Cardiopatías Congénitas Tipo de estudio: Prevalence_studies / Risk_factors_studies Límite: Female / Humans / Pregnancy País/Región como asunto: Europa Idioma: En Revista: Birth Defects Res Año: 2022 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Mortinato / Cardiopatías Congénitas Tipo de estudio: Prevalence_studies / Risk_factors_studies Límite: Female / Humans / Pregnancy País/Región como asunto: Europa Idioma: En Revista: Birth Defects Res Año: 2022 Tipo del documento: Article